Best AI Prior Authorization Software 2026: Top Solutions Compared

Prior authorization remains one of the most time-consuming, costly, and frustrating administrative processes in healthcare. The 2025 AMA Prior Authorization Survey found that physicians spend an average of 14.4 hours per week on prior authorization activities, while 94% of physicians report care delays due to the process. The financial toll is equally severe: authorization-related denials account for 15-20% of all claim denials, manual authorization processing costs $7-$11 per transaction, and an estimated $31 billion is spent annually on prior authorization administration across the US healthcare system.

AI-powered prior authorization software has emerged as the primary solution to this burden, using artificial intelligence and automation to determine requirements, assemble documentation, submit requests, track status, and manage approvals at a fraction of the time and cost of manual processes.

This guide evaluates the 10 leading AI prior authorization solutions in 2026, comparing their capabilities, strengths, and best-fit scenarios to help healthcare organizations choose the right platform for their authorization workflow.

How We Evaluated

Each platform was assessed across seven dimensions critical to prior authorization automation:

1. Requirement determination accuracy — How reliably does the system identify which services require authorization?
2. Automation depth — What percentage of the authorization workflow is automated vs. requiring manual intervention?
3. Multi-channel capability — Can the platform handle electronic, phone, and fax submissions?
4. Intelligence features — Does the system offer predictive capabilities like approval probability scoring or requirement forecasting?
5. Integration breadth — How well does it connect with EHRs, practice management systems, and downstream RCM?
6. Scalability — How does performance hold at high authorization volumes?
7. Broader RCM integration — Does authorization data feed into claims optimization and denial prevention?

Features Matrix

Platform	Electronic PA	Phone Automation	Approval Prediction	Payer Coverage	RCM Integration	Best For
QuickIntell QuickAuth	Yes	AI Voice	Yes	3,500+	Full (native)	Organizations wanting authorization as part of full AI RCM
Infinx	Yes	Human staff	Limited	2,500+	Limited	Dedicated authorization automation with human experts
Rhyme (Cohere Health)	Yes	No	Yes	1,500+	Limited	Health plans and payer-provider collaboration
Availity	Yes	No	No	4,000+	Partial	Organizations needing broad payer connectivity
SureScripts	Yes	No	No	PBMs	No	Pharmacy and medication prior authorization
CoverMyMeds	Yes	No	Limited	PBMs + medical	Partial	Specialty pharmacy and medication access
Waystar	Yes	No	Limited	3,000+	Full (native)	Organizations already using Waystar RCM
Myndshft	Yes	No	Yes	2,000+	Partial	Real-time authorization at point of care
Notable	Yes	No	Limited	1,500+	No	Authorization as part of patient access automation
Olive AI	Yes	No	Limited	2,000+	Partial	Health systems seeking broad automation

1. QuickIntell QuickAuth

Best for: Organizations wanting prior authorization as part of a comprehensive AI revenue cycle platform

QuickIntell's QuickAuth represents the most integrated approach to prior authorization, embedding authorization automation within a full AI-native revenue cycle platform that spans coding, claims, denial management, eligibility, and payment posting.

Key capabilities:

• Predictive requirement detection. AI determines authorization requirements at the point of order using not just payer rule databases but historical pattern analysis. When a payer begins requiring authorization for a previously unrestricted service, QuickAuth detects the pattern from denial data before the rule is formally published, preventing authorization-related denials during the gap between policy change and notification.

• Approval probability scoring. Each authorization request is scored for likelihood of approval based on the clinical documentation available, payer approval patterns for the specific service-diagnosis combination, and the patient's treatment history. A knee MRI for a patient with documented conservative treatment history and 6 weeks of physical therapy scores 94% approval probability; the same MRI without documented conservative treatment scores 31%, triggering a recommendation to obtain additional documentation before submission.

• Multi-channel automation with AI voice. QuickVoice — QuickIntell's AI voice agent — handles phone-based authorizations that still represent 30-40% of total authorization volume. The AI navigates payer phone trees, provides required information, manages hold times, and completes authorization requests without human intervention. This is a significant differentiator: most competing platforms either require human staff for phone authorizations or simply don't handle them.

• Documentation gap analysis. The AI evaluates assembled clinical documentation against payer-specific medical necessity criteria and identifies gaps before submission. Rather than submitting and waiting for a denial, QuickAuth identifies that the payer requires documentation of failed conservative treatment for the requested imaging study and alerts the ordering provider to add this information.

• Closed-loop denial prevention. Authorization data flows directly into QuickIntell's claims optimization engine. If a claim is about to be submitted for a service where authorization was required but not obtained, or where the authorization number doesn't match the billed service, the claim is held for correction. This integration prevents 85-90% of authorization-related denials.

Pricing: Included in QuickIntell's platform pricing (percentage of collections or per-claim models). Also available as a standalone module.

Ideal organization: Multi-specialty practices, health systems, and RCM companies that need authorization automation integrated with broader revenue cycle AI.

2. Infinx

Best for: Organizations seeking dedicated authorization automation with human expert backup

Infinx has built a focused platform around prior authorization and patient access, combining AI technology with trained human authorization specialists.

Key capabilities:

• AI + expert model. Infinx combines machine learning for requirement determination and workflow routing with human authorization specialists who handle complex cases, peer-to-peer reviews, and payer negotiations. This hybrid model provides strong coverage for the most complex authorization scenarios.

• Payer rule database. A continuously updated database of payer authorization requirements spanning thousands of payer-plan combinations. The database is maintained through a combination of automated monitoring and human research.

• Eligibility and benefits integration. Authorization workflows are connected to eligibility verification, ensuring that coverage is confirmed before authorization is initiated and that benefits information informs the authorization strategy.

• Patient financial clearance. Infinx extends beyond authorization into patient financial clearance — estimating patient responsibility, identifying coverage gaps, and supporting financial counseling. This connects the authorization decision to the patient's financial experience.

Limitations: Phone-based authorizations handled by human staff (not AI voice). No broader RCM capabilities — organizations need separate solutions for coding, claims, and denial management. Scalability constrained by human-in-the-loop model.

Pricing: Per-transaction or subscription-based with volume tiers.

Ideal organization: Hospitals and health systems where prior authorization is the dominant operational challenge and complex cases requiring human expertise are frequent.

3. Rhyme (Cohere Health)

Best for: Payer-provider collaboration and clinical intelligence in authorization

Cohere Health (rebranded as Rhyme) takes a unique approach by serving both payers and providers, aiming to streamline the authorization process from both sides of the transaction.

Key capabilities:

• Clinical intelligence engine. Rhyme's AI evaluates clinical information against medical necessity criteria using clinical evidence databases and payer-specific guidelines. The system can determine authorization necessity and make approval recommendations based on clinical data, reducing the back-and-forth between providers and payers.

• Payer-side adoption. Because Rhyme works with health plans to automate their authorization review processes, providers submitting through payers that use Rhyme experience faster turnaround and more transparent decisions. The platform's value increases as more payers adopt it.

• Real-time determination. For qualifying cases, Rhyme can provide real-time or near-real-time authorization decisions by comparing clinical data against the payer's approval criteria algorithmically. This eliminates the days-to-weeks waiting period for straightforward cases.

• Transparent clinical criteria. The platform shows providers what clinical information is needed for approval, reducing guesswork and unnecessary documentation.

Limitations: Effectiveness depends on payer adoption — the platform is most valuable when the patient's payer uses Rhyme for authorization review. Provider-side capabilities are less comprehensive than dedicated provider platforms. Limited broader RCM integration.

Pricing: Varies by engagement model (payer-side vs. provider-side).

Ideal organization: Health systems working with payers that have adopted Rhyme, or organizations interested in a platform that bridges the payer-provider divide in authorization.

4. Availity

Best for: Organizations needing broad payer connectivity for authorization transactions

Availity operates one of the largest healthcare information networks, connecting providers with more than 4,000 payers for transactions including eligibility, claims, and prior authorization.

Key capabilities:

• Broad payer network. Availity's primary strength is connectivity. With relationships spanning the majority of US health plans, Availity provides a single connection point for authorization submissions to virtually any payer. This eliminates the need to manage multiple payer portal logins and submission processes.

• Electronic authorization submission. Standardized electronic prior authorization workflows that route requests to the appropriate payer and return status updates. The process is streamlined but primarily transactional — Availity facilitates the submission rather than applying deep AI to optimize it.

• Real-time transactions. For payers supporting real-time authorization, Availity can return immediate responses. The volume of payers supporting real-time varies but is growing.

• Integration with Availity ecosystem. Organizations using Availity for eligibility and claims can add authorization within the same platform, reducing integration complexity.

Limitations: Primarily a transaction network rather than an AI intelligence platform. Limited predictive capabilities (no approval probability scoring, minimal requirement prediction). No phone or fax automation for payers that don't support electronic authorization. No AI documentation assembly or gap analysis.

Pricing: Transaction-based or subscription models depending on service tier.

Ideal organization: Organizations that need broad payer connectivity for authorization transactions and are comfortable with a primarily transactional (rather than intelligence-driven) approach.

5. SureScripts

Best for: Pharmacy and medication prior authorization

SureScripts operates the nation's largest health information network and has become a primary channel for electronic prescribing — including electronic prior authorization for medications.

Key capabilities:

• Medication PA specialization. SureScripts' CompletEPA solution enables electronic prior authorization for medications directly within the prescribing workflow. When a prescriber orders a medication that requires PA, the request is initiated, clinical questions are presented, and the request is submitted without leaving the EHR.

• EHR integration. CompletEPA is integrated into major EHR platforms, making medication PA a seamless part of the prescribing workflow rather than a separate process.

• PBM connectivity. SureScripts connects to pharmacy benefit managers (PBMs) that process medication authorizations, providing broad coverage for pharmacy PA transactions.

• Real-time response. For payers supporting real-time electronic PA, SureScripts can return authorization decisions within seconds of the request, enabling the prescriber to adjust therapy if needed before the patient leaves the office.

Limitations: Focused exclusively on medication/pharmacy prior authorization. Does not handle medical (non-pharmacy) prior authorization for procedures, imaging, DME, or other services. Not an AI intelligence platform — primarily a transaction channel. No predictive capabilities.

Pricing: Transaction-based, typically through EHR vendor relationships.

Ideal organization: Any organization prescribing medications, as a complement to a medical PA solution. SureScripts addresses medication PA; a separate solution is needed for medical/procedural PA.

6. CoverMyMeds

Best for: Specialty pharmacy and medication access

CoverMyMeds (a McKesson company) is one of the largest electronic prior authorization networks for medications, serving over 750,000 providers and processing hundreds of millions of PA transactions annually.

Key capabilities:

• Broad medication PA coverage. CoverMyMeds covers both pharmacy and medical benefit prior authorization for medications, including specialty drugs that often have the most complex authorization requirements.

• Specialty pharmacy support. Particularly strong in specialty pharmacy — biologics, oncology drugs, and other high-cost medications where authorization requirements are extensive and the financial stakes are high.

• Patient access programs. Integration with manufacturer patient assistance programs, copay cards, and alternative coverage options when authorization is denied or coverage is insufficient.

• Analytics and reporting. Visibility into authorization trends, approval rates, turnaround times, and denial patterns across the medication PA process.

Limitations: Focused on medication authorization. Does not address medical/procedural prior authorization. AI capabilities are developing but currently less advanced than dedicated AI PA platforms. Limited integration with broader RCM workflows.

Pricing: Various models including free basic electronic PA and premium tiers with additional capabilities.

Ideal organization: Organizations with significant specialty pharmacy volumes where medication access and authorization are primary challenges.

7. Waystar

Best for: Organizations already using Waystar for RCM

Waystar, one of the largest RCM technology companies, includes prior authorization capabilities within its broader revenue cycle platform.

Key capabilities:

• Integrated RCM context. Authorization is part of Waystar's broader platform, which includes claims management, eligibility, denial management, and patient payments. Authorization data connects to downstream billing workflows.

• Authorization tracking. Workflow management for authorization requests including status tracking, follow-up alerts, and reporting on authorization turnaround and outcomes.

• Payer connectivity. Waystar's extensive clearinghouse network provides connectivity for electronic authorization transactions across thousands of payers.

• Analytics. Authorization performance metrics, denial tracking for authorization-related denials, and operational reporting.

Limitations: Authorization capabilities are part of a broader platform rather than a deep specialization. AI intelligence in authorization (prediction, approval scoring) is less developed than dedicated AI PA platforms. No voice AI for phone-based authorizations. The platform's strength is in transaction processing rather than AI-driven optimization.

Pricing: Included in Waystar's platform subscription; specific authorization modules may have additional costs.

Ideal organization: Organizations already using Waystar's RCM platform that want authorization management within the same ecosystem.

8. Myndshft

Best for: Real-time authorization at the point of care

Myndshft focuses on real-time prior authorization automation with an emphasis on determining authorization requirements and submitting requests at the point of care — when the order is placed.

Key capabilities:

• Real-time determination. Myndshft's AI evaluates whether authorization is required at the moment a service is ordered, providing an immediate answer that prevents scheduling and care delivery from proceeding without necessary authorization.

• Auto-submission. For services requiring authorization, Myndshft automatically submits requests using available clinical data, reducing the manual steps between order and authorization request.

• Clinical criteria transparency. The platform identifies what clinical information is needed for authorization approval, enabling providers to address documentation gaps before or during submission.

• Approval prediction. Some predictive capability in assessing likelihood of authorization approval based on clinical data and payer patterns.

Limitations: Focused on the determination and submission phases of authorization. Less comprehensive in follow-up management, peer-to-peer coordination, and appeal handling. No voice AI for phone-based authorizations. Newer platform with smaller market footprint than established players.

Pricing: Subscription-based with volume components.

Ideal organization: Organizations prioritizing real-time authorization determination at the point of order, particularly in high-volume ordering environments (imaging centers, surgical practices).

9. Notable Health

Best for: Authorization as part of patient access automation

Notable Health approaches prior authorization as one component of a broader patient access automation platform that includes scheduling, intake, referral management, and patient engagement.

Key capabilities:

• Workflow integration. Authorization is embedded in Notable's patient access workflow — when a patient is scheduled for a service requiring authorization, the authorization process is initiated automatically as part of the pre-visit preparation.

• Documentation assembly. Clinical data is pulled from the EHR to support authorization requests, reducing manual documentation gathering.

• Status visibility. Authorization status is visible within the patient access workflow, ensuring that scheduling and clinical staff know whether authorization is complete before the service date.

• Patient communication. Notable can communicate authorization status and requirements to patients as part of its patient engagement workflow.

Limitations: Authorization is one of many capabilities in a patient access platform, not the sole focus. AI depth in authorization (prediction, approval scoring, multi-channel submission) is less developed than dedicated PA platforms. No voice AI for phone-based authorizations. Does not connect to downstream claims and denial management.

Pricing: Per-patient or per-encounter subscription models.

Ideal organization: Organizations deploying Notable for broader patient access automation who want authorization embedded in the access workflow.

10. Olive AI

Best for: Health systems seeking broad administrative automation

Olive AI positions itself as an "internet of healthcare" platform with automation capabilities spanning multiple administrative functions, including prior authorization.

Key capabilities:

• Broad automation scope. Olive's platform extends beyond prior authorization into eligibility verification, claims management, and other administrative workflows. Authorization is one of several automation targets.

• RPA-based automation. Olive uses robotic process automation to interact with payer systems, automating the mechanical steps of authorization submission and status checking.

• Health system focus. Olive has primarily targeted large health systems, with workflows designed for the complexity and scale of hospital authorization environments.

• Data insights. Authorization data aggregated across Olive's client base provides benchmarking and trend visibility.

Limitations: The company has undergone significant restructuring and strategic shifts. RPA-based approach can be fragile when payer portals change. Authorization is one of many capabilities rather than a deep specialization. Limited predictive AI capabilities compared to purpose-built PA platforms.

Pricing: Enterprise subscription models, typically for health systems.

Ideal organization: Large health systems seeking broad administrative automation where prior authorization is one of several processes to automate.

How to Choose: A Decision Framework

Step 1: Define Your Scope

• Medication PA only? SureScripts or CoverMyMeds are the standard channels.
• Medical PA only? QuickIntell QuickAuth, Infinx, or Myndshft provide the deepest medical PA capabilities.
• Both medication and medical PA? QuickIntell or a combination approach (CoverMyMeds for pharmacy + QuickIntell for medical) covers both domains.

Step 2: Assess Your Complexity

• High volume of phone-based authorizations? QuickIntell's QuickVoice is the only AI voice solution for phone-based PA. Infinx handles phone PA with human staff. All other platforms require your staff for phone-based submissions.
• Complex peer-to-peer requirements? Infinx's human expert model is strong for complex peer-to-peer scenarios. QuickIntell's AI handles most cases with human escalation for exceptions.
• Need approval prediction? QuickIntell and Myndshft offer the most developed approval probability scoring.

Step 3: Consider Broader RCM Needs

• Need standalone PA solution? Infinx, Myndshft, or Rhyme are focused PA platforms.
• Need PA integrated with full RCM? QuickIntell or Waystar embed PA within comprehensive revenue cycle platforms. QuickIntell's AI capabilities in the broader RCM context are more advanced.
• Need PA as part of patient access? Notable embeds PA within patient access workflows.

Step 4: Evaluate Integration Requirements

• Single EHR, single solution? Most platforms integrate with major EHRs. Choose based on capability depth.
• Multi-EHR environment? EHR-agnostic platforms (QuickIntell, Infinx, Availity) provide flexibility.
• Existing RCM technology? If you already use Waystar, adding their PA module reduces integration complexity. If you're evaluating new RCM technology, QuickIntell provides PA plus full RCM in one platform.

The Bottom Line

The prior authorization software market in 2026 offers genuine choices across a spectrum from focused PA automation to comprehensive revenue cycle platforms. The right choice depends on your organization's specific challenges, scale, and broader technology strategy.

For organizations seeking the deepest AI intelligence in authorization — predictive requirement detection, approval probability scoring, and AI voice for phone-based submissions — integrated with a comprehensive revenue cycle platform, QuickIntell QuickAuth provides the most complete solution.

For organizations seeking dedicated human-expert-backed authorization automation as a standalone capability, Infinx provides deep specialization.

For medication-specific authorization, SureScripts and CoverMyMeds remain the standard channels.

For organizations prioritizing payer connectivity breadth, Availity provides the widest network.

Whatever platform you choose, automating prior authorization is no longer optional — the staff time, care delays, and revenue impact of manual authorization processes make AI-powered automation one of the highest-ROI investments in healthcare operations today.

Frequently Asked Questions

What is the average ROI of AI prior authorization software?

Organizations implementing AI prior authorization typically see 50-75% reduction in staff time spent on authorization activities, 60-80% reduction in authorization-related denials, and 40-60% improvement in authorization turnaround time. For a 50-provider multi-specialty group processing 2,000 authorization requests per month, this translates to 3-5 FTEs of recovered staff capacity and $500,000-$1.5 million in prevented authorization-related denials annually. Most organizations achieve positive ROI within 90-120 days of full deployment.

Can AI handle peer-to-peer reviews with payers?

Peer-to-peer reviews — where a payer medical director speaks with the ordering physician — remain primarily human-driven. AI platforms can prepare the clinical documentation for the peer-to-peer, schedule the call, and provide the physician with the specific clinical criteria the payer will evaluate. QuickIntell's QuickVoice can handle many payer phone interactions autonomously, but peer-to-peer clinical discussions between physicians are not currently automated by any platform. Infinx's human experts can assist in preparing and coordinating peer-to-peer reviews.

How do these platforms handle payers that don't support electronic prior authorization?

This varies significantly by platform. QuickIntell uses QuickVoice (AI voice) for phone-based and fax automation for fax-based authorizations. Infinx uses human staff for non-electronic submissions. Most other platforms (Availity, Myndshft, Notable) handle electronic submissions only, leaving phone and fax to the provider's staff. Given that 30-40% of authorization interactions still require non-electronic channels, this capability gap is significant for many organizations.

Should I choose a standalone PA solution or one integrated with RCM?

If prior authorization is your only operational pain point and your coding, claims, denial management, and payment processes are performing well, a standalone solution (Infinx, Myndshft) may be sufficient. However, authorization-related denials are typically 15-20% of total denials — meaning 80-85% of your denial volume has other root causes that a standalone PA solution won't address. For organizations with broader revenue cycle challenges, an integrated platform like QuickIntell addresses authorization AND the other denial categories simultaneously, with cross-function intelligence that improves performance across all areas.

How long does implementation typically take?

Implementation timelines vary by platform: QuickIntell QuickAuth (4-6 weeks as standalone; 8-12 weeks as part of full platform), Infinx (4-8 weeks), Myndshft (4-6 weeks), Notable (6-10 weeks as part of broader platform), Availity (2-4 weeks for authorization add-on), Waystar (4-8 weeks for PA module). Medication-specific platforms (SureScripts, CoverMyMeds) are typically activated through EHR vendor configuration rather than standalone implementation.

Are there regulatory changes that will affect prior authorization automation?

Yes. CMS has finalized rules requiring certain payers (Medicare Advantage, Medicaid managed care, and Qualified Health Plans) to implement electronic prior authorization APIs and respond to authorization requests within specified timeframes. These rules, being implemented through 2026, will increase the percentage of authorizations that can be processed electronically and establish response time requirements that favor automated processing. AI prior authorization platforms are well-positioned to leverage these APIs as they become available, further reducing the manual burden.